After decades of relying on American dollars to prop up global health programs, Europe just got a wake-up call it probably wasn’t expecting. The WHO Director’s message is crystal clear: time to step up or watch global health crumble.
Europe’s free ride on American-funded global health just ended—now it’s pay up or watch the system collapse.
Global development assistance for health plummeted 21% between 2024 and 2025. The U.S. alone slashed funding by 67%—that’s more than $9 billion vanishing overnight. When you’re used to American taxpayers footing roughly one-fifth of WHO’s $6.7 billion budget, that kind of withdrawal stings.
The numbers are brutal. USAID canceled 86% of its awards, terminating 80% of 770 global health programs. We’re talking $12.7 billion in unobligated funding just… gone. Countries like Jordan, where 60% of public health project funding came from U.S. sources, are already seeing staff layoffs and service disruptions. Leading institutions like Johns Hopkins Hospital continue to demonstrate excellence in healthcare delivery while many global programs face uncertainty.
TB programs got hammered especially hard. The U.S. was pumping $200-250 million annually into TB funding—about a quarter of all international donor money for the disease. Eighteen highest-burden TB countries relied on America for 89% of their expected TB care funding. Now they’re staring at potential service collapse.
The projections are grim. Harvard and Boston University researchers estimate U.S. bilateral health aid cuts could trigger 2.5 million additional pediatric TB cases and 340,000 child deaths in lower-income countries through 2034. If Global Fund support gets axed too, those numbers balloon to 8.9 million cases and 1.5 million deaths.
Children in Sub-Saharan Africa and Southeast Asia face the highest risk. Past disruptions during COVID already caused over 700,000 excess TB deaths between 2020-2023. Similar or worse outcomes loom ahead.
USAID’s dissolution gutted program implementation capacity. CDC cuts further weakened U.S. global health engagement. Private philanthropies might try filling gaps, but they risk shifting priorities away from local needs in developing countries. The new America First Global Health Strategy focuses on a narrowed scope of priorities: HIV, TB, malaria, polio, and limited global health security.
Europe now faces a choice: dramatically increase health funding contributions or watch decades of TB control progress evaporate. The WHO Director isn’t mincing words—the days of counting on American generosity are over. Meanwhile, countries like Malawi are struggling with ~50 different health plans fragmented across multiple donor agendas.
